Euclidean Capital LLC Portfolio Holdings
Euclidean Capital LLC
- $265 Million
- Q1 2025
Euclidean Capital LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $265 Million distributed in 11 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ishares Msci India Index Fund with a value of $125M, Vanguard Ftse All World Ex Us with a value of $121M, Foghorn Therapeutics Inc. with a value of $5.74M, Oric Pharmaceuticals, Inc. with a value of $5.52M, and Pmv Pharmaceuticals, Inc. with a value of $2.86M.
Examining the 13F form we can see an decrease of $470M in the current position value, from $735M to 265M.
Euclidean Capital LLC is based out at New York, NY
Below you can find more details about Euclidean Capital LLC portfolio as well as his latest detailed transactions.